Reperfusion therapy fails to improve limb ischemia in clinical trial

07/30/2013 | TCTMD.com

The use of controlled reperfusion techniques for patients undergoing surgical revascularization did not improve their recovery from critical limb ischemia in a randomized study of 174 patients conducted in Germany. The study showed that the rates of amputation-free survival after four weeks and one year remained the same between the controlled reperfusion group and those who just had surgery.

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL